6Duncan J,Campbell.The Kallikrein-kinin system in humans[J].Clinical and Experimental Pharmacology and Physiology,2001,28:1060-1065.
7Deshamdra M, Raidoo, Kanti D. Pathophysilolgy of kallikrein-kinin system in mammalian nervous tissue [J]. Pharmacol Ther, 1998,79:105-129
8Ding-Zhou L, Margaill I, Palmier B. LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia[J]. Br J Pharmacol, 2003,139:1539-1547
9Chao J, Chao L. Experimental therapy with tissue kallikrein against cerebral ischemia[J]. Front Biosci, 2006,1:1323-1327
10Souza DG, Pinho V, Pesquero JL, et al. Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury[J]. Br J Pharmacol, 2003,139:129-139
8Clarke M, Oxman AD. Cochrane Reviewers, Handbook4.1 [ updated June 2000 ]. In : Review Manager (RevMan) [ CP/ OL]. Version 4.1. Oxford, England: The Cochrane Collaboration, 2000.
9X in CF, Y in H,Borbngan CV, et al KaIIikrein gene transfer pro-tects against ischem ie stroke bypiom o tingglial cellm ig raton and inhibiting apoplosis hypertension ( S0194 - 911 X), 2004.43 ( 2 ) : 452 - 459.
